Schonfeld Strategic Advisors LLC Pds Biotechnology Corp Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.55 - $4.02 $39,270 - $61,907
15,400 New
15,400 $45,000
Q3 2022

Nov 14, 2022
BUY
$2.97 - $5.79 $3,267 - $6,369
1,100 Added 7.01%
16,800 $50,000
Q2 2022

Aug 15, 2022
BUY
$3.05 - $6.68 $47,885 - $104,876
15,700 New
15,700 $57,000

Others Institutions Holding PDSB

# of Institutions
65
Shares Held
4.05M
Call Options Held
253K
Put Options Held
70.4K
View Full List

About PDS Biotechnology Corp

PDSB Quotes by TradingView
  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $43M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email